CCM
ADAG

CAAS Capital Management’s Adagene ADAG Stock Holding History

CAAS Capital Management’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-69,000
Closed -$1.24M – 1018
2021
Q1 		$1.24M Buy
+69,000
New +$1.57M 0.01% 733

Other funds holding ADAG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SVI
Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

CAAS Capital Management's ADAG Position: Q2 2021 in Review

CAAS Capital Management sold out of Adagene (ADAG) in Q2 2021, closing a stake of 69,000 shares — an estimated $1.24M sold.

CAAS Capital Management first reported a position in ADAG in Q1 2021 and held it in 1 quarter. The position peaked at $1.24M in Q1 2021. 16 funds tracked by Wall St. Rank hold ADAG as of Q2 2021.

  • CAAS Capital Management reported no remaining Adagene position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 69,000 Adagene shares in Q2 2021, an estimated $1.24M.
  • CAAS Capital Management first reported a position in Adagene in Q1 2021 and held it in 1 quarter.
  • CAAS Capital Management's Adagene position peaked at $1.24M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Adagene as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.